Antiestrogen
Top View
- Differences Between Estrogen- and Antiestrogen-Estrogen Receptor Complexes from Human Breast Tumors Identified with an Antibody Raised Against the Estrogen Receptor1
- Oral Contraceptive Pills
- Tamoxifen and Endometrial Cancer: a Janus-Headed Drug
- White Paper Environmental Endocrine Disrtuptors and Its Potential Impacts on Public Health and the Environment in New Jersey
- In Vivo Prediction of Response to Antiestrogen Treatment in Estrogen Receptor–Positive Breast Cancer
- O O O Castrate Control COHP24 O (57) Abstract: Disclosed Herein Are Compositions and Methods for Modulating the Androgen Receptor
- Estrogen and Antiestrogen Regulation of Cell Cycle Progression in Breast Cancer Cells
- High Inhibitory Activity of a New Antiestrogen, RU 16117 (Lla-Methoxy Ethinyl Estradiol), on the Development of Dimethylbenz(A)Anthracene-Induced Mammary Tumors
- Molecular Mechanism for Breast Cancer Incidence in the Women's Health Initiative
- Femara® (Letrozole Tablets)
- Estetrol Review: Profile and Potential Clinical Applications
- PRODUCT MONOGRAPH Norethindrone Tablets, USP 0.35
- The Molecular Pharmacology of Estrogen Receptor Modulators: Implications for the Treatment of Breast Cancer
- A Targeted-Covalent Inhibitor of 17-HSD1 Blocks Two
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
- Chloroquine Inhibits Autophagy to Potentiate Antiestrogen Responsiveness in Erþ Breast Cancer
- The Uterine and Vascular Actions of Estetrol Delineate a Distinctive Profile of Estrogen Receptor a Modulation, Uncoupling Nuclear and Membrane Activation
- NOLVADEX (Tamoxifen Citrate) TABLETS